Furthermore, a serum-based enzyme-linked immunosorbent assay using a monoclonal antibody that can detect PAGE4 at a low ng/mL level can distinguish patients with symptomatic and asymptomatic BPH with high sensitivity and specificity [84]. Here, PAGE4 is linked to benign prostatic hyperplasia.